Blog: ZYMEWORKS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – marketscreener.com

ITEM 7.01 REGULATION FD DISCLOSURE

On January 6, 2022, Zymeworks Inc. (“Zymeworks”) issued a press release
announcing that Neil Klompas, Zymeworks’ Chief Operating Officer and Chief
Financial Officer, will present at the upcoming 40th Annual J.P. Morgan
Healthcare Conference on January 11, 2022 at 9:45 a.m. ET.

On January 6, 2022, Zymeworks filed this press release with the Canadian
securities regulatory authorities on the System for Electronic Document Analysis
and Retrieval (“SEDAR”) at http://www.sedar.com.

A copy of this press release is attached as Exhibit 99.1 hereto.

The information provided under this Item (including Exhibit 99.1, attached
hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933, as amended, or the Exchange Act,
except as expressly set forth by specific reference in such a filing.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS



  (d) Exhibits



Exhibit
  No.     Description

99.1        Press Release dated January 6, 2022.

104       Cover Page Interactive Data File (embedded as Inline XBRL document).

——————————————————————————–

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s